Cite
HARVARD Citation
Allsup, D. et al. (2022). Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American journal of hematology. 97 (5), pp. E168-E171. [Online].